Among antioxidant enzymes, our recent studies have shown evidence of impaired functioning of the enzyme paraoxonase 1 (PON1) associated to high-density lipoprotein (HDL) in individuals with AD, with reduced protein levels and enzyme activity (60, 61)
Zhang R, Jiang B, Fan K, Gao L, Yan X
This article will explore GLP-1 drugs, their types, how to take them, risks, side effects, and the common questions people have about GLP-1 medications
A lack of carnitine in the body causes an interference in the processing of food for energy
Common Mistakes in How BPC-157 Is Interpreted Mistake 01 Treating Rodent Results as Human Outcomes The most pervasive error in interpreting BPC-157 research is reading rat study outcomes as if they were human clinical trial results
Gastroenterol 2012;142(Suppl